✦ LIBER ✦

Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan

✍ Scribed by Chong, G; Dickson, J L B; Cunningham, D; Norman, A R; Rao, S; Hill, M E; Price, T J; Oates, J; Tebbutt, N

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine and mitomycin C in patients

✍ Alliot, C 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 47 KB

Reply: Capecitabine and mitomycin C in p

✍ Chong, G; Cunningham, D 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 43 KB

Bevacizumab in combination with biweekly

✍ García-Alfonso, P; Muñoz-Martin, A J; Alvarez-Suarez, S; Jerez-Gilarranz, Y; Rie 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 243 KB

Mitomycin-C and capecitabine as third-li

✍ Do Hyoung Lim; Young Suk Park; Byeong-Bae Park; Sang Hoon Ji; Jeeyun Lee; Keon W 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 200 KB

Capecitabine and bevacizumab as first-li

✍ Feliu, J; Safont, M J; Salud, A; Losa, F; García-Girón, C; Bosch, C; Escudero, P 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB

Phase II study of biweekly irinotecan an

✍ Yasuhide Yamada; Kuniaki Shirao; Ichinosuke Hyodo; Yasuaki Arai; Tadamichi Denda 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 190 KB